Physician profile
Arnold J Valenson
NPI 1831337096
$36,171.70
in general payments reported to CMS, 2019-2025
17 companies · $20K in 2025
The $20K reported for 2025 was more than what 93% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $470 · 2021: $489 · 2022: $1,318 · 2023: $1,548 · 2024: $12K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $32K · Food and Beverage: $1,145 · Travel and Lodging: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $32,138.89 |
| Food and Beverage | $1,145.26 |
| Travel and Lodging | $255.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $32,394.41 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Siemens Medical Solutions USA, INC. | $1,324.25 | 2021-2022 | |
| Tactile Systems Technology INC | $885.25 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $498.85 | 2021-2024 | Xarelto |
| Medtronic Vascular, INC. | $376.29 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $186.13 | 2025 | Venclose Maven Catheter, Venovo |
| Boston Scientific Corporation | $109.76 | 2023-2025 | Varithena Administration Pack, Watchman Flx |
| Pfizer INC. | $88.22 | 2022-2025 | |
| Ets Wound Care LLC | $68.89 | 2024 | Mirragen Advanced Wound Matrix |
| Cashflow Solutions, LLC | $55.64 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Resmed Corp | $43.41 | 2022-2023 | |
| Biocompatibles, INC. | $37.20 | 2019 | |
| Medtronic, INC. | $36.65 | 2021-2025 | Venaseal |
| Mimedx Group, INC. | $18.58 | 2024 | |
| Abbvie INC. | $18.51 | 2023 | Dalvance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $16.31 | 2020 | |
| Kerecis Limited | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Valenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.